Danaher Q3 Preview: Market Share Positive aspects In Molecular Testing (NYSE:DHR)
This text was written byObserveGreater than 15 years {of professional} funding expertise in world equities throughout all sectors. My funding ...
Thursday, May 8, 2025
Tag: NYSEDHR
Danaher: Bioprocessing Should Drive Long-Term Growth (NYSE:DHR)
onurdongel Investment Thesis Danaher (NYSE:DHR) has declined another 13% since my last coverage in January and the premium compounder is ...
Danaher shows takeover interest in contract manufacturer Catalent (NYSE:DHR)
Nastassia Samal Life sciences company Danaher Corporation (NYSE:DHR) has expressed interest in acquiring the contract manufacturer Catalent (NYSE:CTLT), Bloomberg reported ...
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.